GILD Long

AstrasZeneca deal or possible approvals of its Covid-19 drug Remdesivir may trigger the sharp increase to the upper bound of the daily trend.
SL below daily trend level.
Beyond Technical AnalysisFundamental AnalysisGILDTrend Analysis

Exención de responsabilidad